FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Equine veterinary journal2026; doi: 10.1002/evj.70171

Clinical audit on antimicrobial stewardship effectiveness in reducing antimicrobial-resistant bacterial colonisation in hospitalised horses.

Abstract: International guidelines support the One Health approach and recommend antimicrobial stewardship programmes (ASPs) in veterinary medicine. National data on antimicrobial-resistant bacterial colonisation rates (AMRb CR) in horses remain limited. Objective: To evaluate the effectiveness of an ASP in reducing AMRb CR in a Veterinary Teaching Hospital using a clinical audit. Methods: Clinical audit. Methods: In Autumn 2021 active AMR surveillance in Perinatology/Reproduction and Internal Medicine Units planned; January-July 2022-first audit cycle (A1); Autumn 2022-review and implementation of antimicrobial use and biosecurity policies; January-July 2023-re-audit (A2) after ASP application. In total, 328 hospitalised horses (foals and adults) were included. Nasal and rectal swabs collected at admission/birth and discharge/euthanasia/death were tested for methicillin-resistant Staphylococci (MRS), third-generation cephalosporins-resistant Gram-negative bacteria (3GCR-GNB) and carbapenem-resistant Gram-negative bacteria (CR-GNB). Fisher's exact test and Mann-Whitney U test evaluated differences in AMRb CR, antimicrobial use, and hospitalisation length between A1 and A2. Results: In A2, there was a significant reduction in overall AMRb CR (foals: OR = 0.27, 95% CI 0-0.87, p = 0.03; adults: OR = 0.39, 95% CI 0-0.77, p = 0.01), in MRS CR (foals: OR = 0.30, 95% CI 0-0.57, p < 0.001; adults OR = 0.42, 95% CI 0-0.83, p = 0.01), in 3GCR-GNB CR (adults: OR = 0.47, 95% CI 0-0.89, p = 0.02; total: OR = 0.53, 95% CI 0-0.87, p = 0.01), and in CR-GNB CR (foals: OR = 0.26, 95% CI 0-0.90, p = 0.03; total: OR = 0.24, 95% CI 0-0.78, p = 0.02). Highest priority critically important antimicrobials use decreased (foals: OR = 0.17, 95% CI 0-0.41, p < 0.001; total: OR = 0.20, 95% CI 0-0.43, p < 0.001), as did antibiotic treatment duration (foals: A1 7.75 ± 11.5, A2 3.70 ± 4.63 days, p < 0.001; adults:A1 3.70 ± 4.63, A2 0.74 ± 2.27 days, p = 0.04), and hospitalisation length (foals ≤30 days old: A1 18.1 ± 18.9, A2 9.77 ± 7.01 days, p = 0.05; total: A1 16.0 ± 15.1, A2 12.6 ± 11.4 days, p = 0.03). Conclusions: Lack of genotypic analysis and exclusion of the surgery unit. Conclusions: This clinical audit confirms the effectiveness of the implemented ASP and supports its adoption in comparable veterinary settings. INTRODUÇÃO: Diretrizes internacionais apoiam a abordagem One Health e recomendam a implementação de programas de uso racional de antimicrobianos (ASP, do inglês antimicrobial stewardship programmes) na medicina veterinária. No entanto, os dados nacionais sobre taxas de colonização por bactérias resistentes a antimicrobianos (CBRA) em cavalos permanecem limitados. Objective: Avaliar a efetividade de um ASP na redução das taxas de CBRA em um Hospital Veterinário Universitário por meio de uma auditoria clínica. Unassigned: Outono de 2021—planejamento da vigilância ativa de resistência antimicrobiana nas Unidades de Perinatologia/Reprodução e Clínica Médica. Janeiro–julho de 2022—primeiro ciclo de auditoria (A1). Outono de 2022—revisão e implementação de políticas de uso de antimicrobianos (AMU) e biossegurança. Janeiro–julho de 2023—reauditoria (A2) após a aplicação do ASP. MÉTODOS: Foram incluídos 328 cavalos hospitalizados (potros e adultos). Swabs nasais e retais coletados na admissão/nascimento e na alta/eutanásia/óbito foram testados para estafilococos resistentes à meticilina (ERM), bactérias Gram‐negativas resistentes a cefalosporinas de terceira geração (BGN‐RC3G) e bactérias Gram‐negativas resistentes a carbapenêmicos (BGN‐RCARB). Fisher's exact e de Mann–Whitney U foram utilizados para avaliar diferenças nas taxas de CBRA, no uso de antimicrobianos e no tempo de hospitalização entre A1 e A2. Results: Em A2, foi observada redução significativa na taxa global de CBRA (potros: OR = 0,27, IC95% 0–0,87, p = 0,03; adultos: OR = 0,39, IC95% 0–0,77, p = 0,01), bem como nas taxas de CBRA por ERM (potros: OR = 0,30, IC95% 0–0,57, p < 0,001; adultos: OR = 0,42, IC95% 0–0,83, p = 0,01), BGN‐RC3G (adultos: OR = 0,47, IC95% 0–0,89, p = 0,02; total: OR = 0,53, IC95% 0–0,87, p = 0,01) e BGN‐RCARB (potros: OR = 0,26, IC95% 0–0,90, p = 0,03; total: OR = 0,24, IC95% 0–0,78, p = 0,02). O uso de antimicrobianos criticamente importantes de maior prioridade diminuiu (potros: OR = 0,17, IC95% 0–0,41, p < 0,001; total: OR = 0,20, IC95% 0–0,43, p < 0,001), assim como a duração do tratamento antimicrobiano (potros: A1 7,75 ± 11,5; A2 3,70 ± 4,63 dias, p < 0,001; adultos: A1 3,70 ± 4,63; A2 0,74 ± 2,27 dias, p = 0,04) e o tempo de hospitalização (potros ≤30 dias de idade: A1 18,1 ± 18,9; A2 9,77 ± 7,01 dias, p = 0,05; total: A1 16,0 ± 15,1; A2 12,6 ± 11,4 dias, p = 0,03). PRINCIPAIS LIMITAÇÕES: Ausência de análise genotípica e exclusão da Unidade de Cirurgia. CONCLUSÃO: Esta auditoria clínica confirma a efetividade do ASP implementado e sustenta sua adoção em contextos veterinários comparáveis.
© 2026 EVJ Ltd.
Get Full Text
Publication Date: 2026-05-12 PubMed ID: 42117890DOI: 10.1002/evj.70171Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study audited the effectiveness of an antimicrobial stewardship program (ASP) in reducing antimicrobial-resistant bacterial colonisation in hospitalized horses at a Veterinary Teaching Hospital.
  • By comparing data before and after ASP implementation, the research demonstrated significant reductions in resistance rates, antimicrobial use, treatment duration, and hospital stay length.

Introduction and Background

  • International guidelines endorse the One Health approach, promoting integrated action on human, animal, and environmental health.
  • Antimicrobial Stewardship Programs (ASPs) aim to optimize antimicrobial use to combat resistance.
  • In veterinary medicine, particularly equine care, data on antimicrobial-resistant bacterial colonisation rates (AMRb CR) are scarce at the national level.
  • The study addressed this gap by evaluating an ASP’s impact within a Veterinary Teaching Hospital.

Study Objective

  • To evaluate whether implementing an ASP could reduce the colonisation rates of antimicrobial-resistant bacteria in hospitalized foals and adult horses.

Methods

  • Study Design: Clinical audit involving two audit cycles conducted before and after the implementation of the ASP.
  • Timeline:
    • Autumn 2021: Planning active antimicrobial resistance surveillance in Perinatology/Reproduction and Internal Medicine Units.
    • January to July 2022: First audit cycle (A1), baseline data collection
    • Autumn 2022: Policy review and implementation of enhanced antimicrobial use and biosecurity protocols.
    • January to July 2023: Re-audit (A2) following ASP application.
  • Population: 328 hospitalized horses (both foals and adults).
  • Sample Collection: Nasal and rectal swabs taken at admission/birth and discharge/euthanasia/death.
  • Microbiological Testing: Screening for three key resistant bacterial groups:
  • Data Analysis: Fisher’s exact test and Mann–Whitney U test compared antimicrobial resistance rates, antibiotic use, and length of hospital stay between the two audit cycles.

Key Results

  • Antimicrobial Resistance Reductions in Audit Cycle 2:
    • Overall reduction in antimicrobial-resistant bacterial colonisation rates (AMRb CR):
      • Foals: Odds Ratio (OR) = 0.27, p = 0.03
      • Adults: OR = 0.39, p = 0.01
    • Reduction in methicillin-resistant Staphylococci colonisation:
      • Foals: OR = 0.30, p < 0.001
      • Adults: OR = 0.42, p = 0.01
    • Reduction in third-generation cephalosporin-resistant Gram-negative bacteria:
      • Adults: OR = 0.47, p = 0.02
      • Total population: OR = 0.53, p = 0.01
    • Reduction in carbapenem-resistant Gram-negative bacteria:
      • Foals: OR = 0.26, p = 0.03
      • Total population: OR = 0.24, p = 0.02
  • Antimicrobial Use Changes:
    • Use of highest priority critically important antimicrobials decreased:
      • Foals: OR = 0.17, p < 0.001
      • Total: OR = 0.20, p < 0.001
    • Antibiotic treatment duration shortened significantly:
      • Foals: from 7.75 ± 11.5 days (A1) to 3.70 ± 4.63 days (A2), p < 0.001
      • Adults: from 3.70 ± 4.63 days (A1) to 0.74 ± 2.27 days (A2), p = 0.04
  • Hospitalization Length:
    • Foals (≤ 30 days old): reduced from 18.1 ± 18.9 days to 9.77 ± 7.01 days, p = 0.05
    • Total population: reduced from 16.0 ± 15.1 days to 12.6 ± 11.4 days, p = 0.03

Limitations

  • The study did not include genotypic analysis of bacteria, limiting understanding of specific resistance mechanisms or strain relatedness.
  • The Surgery Unit was excluded from the audit, so findings may not fully reflect resistance dynamics or stewardship impact in surgical patients.

Conclusions and Implications

  • The clinical audit confirmed that implementing an ASP led to meaningful reductions in antimicrobial-resistant bacterial colonisation among hospitalized horses.
  • There was a corresponding reduction in the use of critical antimicrobials and shorter treatment durations, indicating improved antimicrobial use practices.
  • Shortened hospital stays suggest potential benefits for animal welfare and resource use.
  • The findings support adopting similar ASPs in other veterinary hospitals to combat antimicrobial resistance and promote animal and public health under the One Health paradigm.

Cite This Article

APA
Mazzola K, Lanci A, Piva S, Schisa V, Mariella J, Scarpellini R, Freccero F, De Carolis E, Tumietto F, Castagnetti C. (2026). Clinical audit on antimicrobial stewardship effectiveness in reducing antimicrobial-resistant bacterial colonisation in hospitalised horses. Equine Vet J. https://doi.org/10.1002/evj.70171

Publication

Equine veterinary journal
ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Mazzola, Karen
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Lanci, Aliai
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Piva, Silvia
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Schisa, Viviana
  • Department of Statistical Sciences, University of Bologna, Bologna, Italy.
Mariella, Jole
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Scarpellini, Raffaele
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
Freccero, Francesca
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
De Carolis, Erica
  • Department of Statistical Sciences, University of Bologna, Bologna, Italy.
Tumietto, Fabio
  • Unit of Antimicrobial Stewardship, Local Health Authority of Bologna, Bologna, Italy.
Castagnetti, Carolina
  • Department of Veterinary Medical Sciences, University of Bologna, Bologna, Italy.
  • Health Science and Technologies Interdepartmental Center for Industrial Research (HST-ICIR), University of Bologna, Bologna, Italy.

References

This article includes 109 references
  1. Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: a global emerging threat to public health systems.. Crit Rev Food Sci Nutr 2017;57:2857–2867.
  2. World Health Organization WHO. Global action plan on antimicrobial resistance. Geneva: WHO; 2015.
  3. Caudell MA, Mair C, Subbiah M, Matthews L, Quinlan RJ, Quinlan MB. Identification of risk factors associated with carriage of resistant Escherichia coli in three culturally diverse ethnic groups in Tanzania: a biological and socioeconomic analysis.. Lancet Planet Health 2018;2:489–497.
    doi: 10.1016/s2542-5196(18)30225-0google scholar: lookup
  4. Gharaibeh MH, Abutarbush SM, Mustafa FG, Lafi SQ, Halaiqa MS. Identification of risk factors associated with antimicrobial resistance in equine fecal Escherichia coli isolates.. Infect Genet Evol 2020;83:104317.
  5. Steinman A, Navon‐Venezia S. Antimicrobial resistance in horses.. Animals 2020;10:1161.
    doi: 10.3390/ani10071161google scholar: lookup
  6. Walther B, Tedin K, Lübke‐Becker A. Multidrug‐resistant opportunistic pathogens challenging veterinary medicine.. Vet Microbiol 2017;200:71–78.
  7. Gilbertie JM, Schnabel LV, Stefanovski D, Kelly DJ, Jacob ME, Schaer TP. Gram‐negative multidrug‐resistant bacteria influence survival to discharge for horses with septic synovial structures: 206 cases (2010–2015).. Vet Microbiol 2018;226:64–73.
  8. Van Spijk JN, Schmitt S, Schoster A. Infections caused by multidrug‐resistant bacteria in an equine hospital (2012–2015).. Equine Vet Educ 2019;31(12):653–658.
    doi: 10.1111/eve.12837google scholar: lookup
  9. Léon A, Castagnet S, Maillard K, Paillot R, Giard JC. Evolution of in vitro antimicrobial susceptibility of equine clinical isolates in France between 2016 and 2019.. Animals 2020;10:812.
  10. Shnaiderman‐Torban A, Meltzer L, Zilberman‐Daniels T, Navon‐Venezia S, Cohen A, Sutton GA. Infections caused by extended‐spectrum beta‐lactamase‐producing Enterobacterales in hospitalized neonatal foals: can colonization predict infection?. J Vet Intern Med 2025;39:e17299.
    doi: 10.1111/jvim.17299google scholar: lookup
  11. Kabir A, Lamichhane B, Habib T, Adams A, El‐Sheikh Ali H, Slovis NM. Antimicrobial resistance in equines: a growing threat to horse health and beyond—a comprehensive review.. Antibiotics (Basel) 2024;13(8):713.
    doi: 10.3390/antibiotics13080713google scholar: lookup
  12. Blagojevic C, Brown KA, Diong C, Fridman DJ, Johnstone J, Langford BJ. Long‐term risk of infection among patients colonized with antimicrobial‐resistant pathogens: a population‐wide cohort study.. Open Forum Infect Dis 2024;11(12):ofae712.
    doi: 10.1093/ofid/ofae712google scholar: lookup
  13. Weese JS, Rousseau J, Willey BM, Archambault M, McGeer A, Low DE. Methicillin‐resistant Staphylococcus aureus in horses at a veterinary teaching hospital: frequency, characterization, and association with clinical disease.. J Vet Intern Med 2006;20:182–186.
  14. Mulvey MR, Simor AE. Antimicrobial resistance in hospitals: how concerned should we be?. CMAJ 2009;180:408–415.
    doi: 10.1503/cmaj.080239google scholar: lookup
  15. Chng KR, Li C, Bertrand D, Ng AHQ, Kwah JS, Low HM. Cartography of opportunistic pathogens and antibiotic resistance genes in a tertiary hospital environment.. Nat Med 2020;26:941–951.
    doi: 10.1038/s41591-020-0894-4google scholar: lookup
  16. Guardabassi L. Veterinary hospital‐acquired infections: the challenge of MRSA and other multidrug‐resistant bacterial infections in veterinary medicine. Vet J 2012;193:307–308.
    doi: 10.1016/j.tvjl.2012.04.005google scholar: lookup
  17. Maddox TW, Williams NJ, Clegg PD, O'Donnell AJ, Dawson S, Pinchbeck GL. Longitudinal study of antimicrobial‐resistant commensal Escherichia coli in the faeces of horses in an equine hospital. Prev Vet Med 2011;100:134–145.
    doi: 10.1016/j.prevetmed.2011.02.006google scholar: lookup
  18. van Duijkeren E, Moleman M, Sloet van Oldruitenborgh‐Oosterbaan MM. Methicillin‐resistant Staphylococcus aureus in horses and horse personnel: an investigation of several outbreaks. Vet Microbiol 2010;141(1–2):96–102.
    doi: 10.1016/j.vetmic.2009.08.009google scholar: lookup
  19. Khairullah AR, Sudjarwo SA, Effendi MH, Ramandinianto SC, Widodo A, Riwu KHP. A review of horses as a source of spreading livestock‐associated methicillin‐resistant Staphylococcus aureus to human health. Vet World 2022;15(8):1906–1915.
  20. Shnaiderman‐Torban A, Paitan Y, Arielly H, Kondratyeva K, Tirosh‐Levy S, Abells Sutton G. Extended‐spectrum‐lactamase‐producing Enterobacteriaceae in hospitalized neonatal foals: prevalence, risk factors for shedding and association with infection. Animals 2019;9:600.
    doi: 10.3390/ani9090600google scholar: lookup
  21. Loncaric I, Rosel AC, Szostak MP, Licka T, Allerberger F, Ruppitsch W. Broad‐spectrum cephalosporin‐resistant Klebsiella spp. isolated from diseased horses in Austria. Animals 2020;10:332.
  22. Shnaiderman‐Torban A, Marchaim D, Navon‐Venezia S, Lubrani O, Paitan Y, Arielly H. Third generation cephalosporin resistant Enterobacterales infections in hospitalized horses and donkeys: a case–case–control analysis. Antibiotics 2021;10:155.
    doi: 10.3390/antibiotics10020155google scholar: lookup
  23. Thomson K, Eskola K, Eklund M, Suominen K, Määttä M, Junnila J. Characterisation of and risk factors for extended‐spectrum β‐lactamase producing Enterobacterales (ESBL‐E) in an equine hospital with a special reference to an outbreak caused by Klebsiella pneumoniae ST307:CTX‐M‐1. Acta Vet Scand 2022;64:4.
    doi: 10.1186/s13028-022-00621-6google scholar: lookup
  24. Cassini A, Diaz Högberg L, Plachouras D, Quattrocchi A, Hoxha A, Skov Simonsen G. Attributable deaths and disability‐adjusted life‐years caused by infections with antibiotic‐resistant bacteria in the EU and the European economic area in 2015: a population‐level modelling analysis. Lancet Infect Dis 2019;19:56–66.
  25. European Centre for Disease Prevention and Control (ECDC) Country visit to Italy to discuss antimicrobial resistance issues. 2017. Available from: https://www.ecdc.europa.eu/en/publications-data/ecdc-country-visit-italy-discuss-antimicrobial-resistance-issues
  26. European Centre for Disease Prevention and Control (ECDC). Assessing the health burden of infections with antibiotic‐resistant bacteria in the EU/EEA, 2016–2020. 2022. Available from: https://www.ecdc.europa.eu/en/publications-data/health-burden-infections-antibiotic-resistant-bacteria-2016-2020
  27. European Centre for Disease Prevention and Control ECDC, World Health Organization WHO. Antimicrobial resistance surveillance in Europe 2022–2020 data. Copenhagen: Regional Office for Europe; 2022.
  28. European Centre for Disease Prevention and Control ECDC, World Health Organization WHO. Antimicrobial resistance surveillance in Europe 2023–2021 data. Stockholm: Publications Office of the European Union; 2023.
    doi: 10.2900/63495google scholar: lookup
  29. GTC‐AMR Gruppo di lavoro per il coordinamento della strategia nazionale di contrasto dell'antimicrobico‐resistenza. Piano Nazionale di Contrasto all'Antibiotico‐Resistenza (PNCAR) 2022–2025. 2022.
  30. Bacci S, Meucci V, Sgorbini M, De Marchi L, Pirone A, Pretti C. Pattern of prescriptions and prudent use of antimicrobial in horse practice at a veterinary teaching hospital.. Res Vet Sci 2024;168:105140.
  31. Van den Eede A, Hermans K, Van den Abeele A. Methicillin‐resistant Staphylococcus aureus (MRSA) on the skin of long‐term hospitalised horses.. Vet J 2012;193:408–411.
  32. Scarpellini R, Leal Vélez De Mendizábal L, Quevedo‐Caraballo S, Blanco JL, García ME, Pérez‐Sancho M. Active surveillance of antimicrobial resistance in companion animals: a pilot study in a Spanish veterinary teaching hospital.. Clin Microbiol Infect 2024;30(2):102169.
    doi: 10.1016/j.cimid.2024.102169google scholar: lookup
  33. Sijtsema M, Stringer T, Hopman NEM, van der Graaf‐van Bloois L, Duim B, van den Brom‐Spierenburg A. Active surveillance in an equine intensive care unit identifies clusters of ESKAPEE pathogens in the veterinary hospital environment.. Vet Microbiol 2025;303:110439.
    doi: 10.1016/j.vetmic.2025.110439google scholar: lookup
  34. Dowling PM, Prescott JF, Baptiste KE. Antimicrobial therapy in veterinary medicine. 6th ed. Hoboken, NJ: John Wiley & Sons; 2024. p. 401–423, 445–85, 547–75.
  35. Prescott JF. Outpacing the resistance tsunami: antimicrobial stewardship in equine medicine, an overview.. Equine Vet Educ 2021;33:539–545.
  36. Hardefeldt LY, Gilkerson JR, Billman‐Jacobe H, Stevenson MA, Thursky K, Bailey KE. Barriers to and enablers of implementing antimicrobial stewardship programs in veterinary practices.. J Vet Intern Med 2018;32:1092–1099.
    doi: 10.1111/jvim.15083google scholar: lookup
  37. Hopman NEM, Portengen L, Hulscher MEJL, Heederik DJJ, Verheij TJM, Wagenaar JA. Implementation and evaluation of an antimicrobial stewardship programme in companion animal clinics: a stepped‐wedge design intervention study.. PLoS One 2019;14(11):e0225124.
    doi: 10.1371/journal.pone.0225124google scholar: lookup
  38. Feyes EE, Diaz‐Campos D, Mollenkopf DF, Horne RL, Soltys RC, Ballash GA. Implementation of an antimicrobial stewardship program in a veterinary medical teaching institution.. J Am Vet Med Assoc 2021;258:2–178.
    doi: 10.2460/javma.258.2.170google scholar: lookup
  39. Singleton DA, Rayner A, Brant B, Smyth S, Noble PM, Radford AD. A randomised controlled trial to reduce highest priority critically important antimicrobial prescription in companion animals.. Nat Commun 2021;12:1593.
    doi: 10.1038/s41467-021-21864-3google scholar: lookup
  40. Rose N, Toews L, Pang DSJ. A systematic review of clinical audit in companion animal veterinary medicine.. BMC Vet Res 2016;12:40.
    doi: 10.1186/s12917-016-0661-4google scholar: lookup
  41. Hodgson C, Pinchbeck G. A prospective multicentre survey of complications associated with equine castration to facilitate clinical audit.. Equine Vet J 2019;51(4):435–439.
  42. Spanton JA, Smith L, Mair TS. A clinical audit of the prevalence of colic in the 48 hours after gastroscopy in 436 horses.. Equine Vet Educ 2020;32:12–15.
  43. Ceriotti S, Westerfeld R, Bonilla AG, Pang DS. Use of clinical audits to evaluate timing of preoperative antimicrobials in equine surgery at a veterinary teaching hospital. Front Vet Sci 2021;8:630111.
  44. Bertuglia A, Bobbio A, Pallante M, Memoli G, Pagliara E, D'Aguì E. Perioperative complications in horses: the introduction of an audit program in a hospital setting. Proceedings of the 29th SIVE international congress Florence: SIVE (Italian Society of Equine Veterinarians); 2024. p. 547–548.
  45. Dodd NA, Smith MR. A clinical audit of the intravenous fluid therapy given to hospitalised horses. Equine Vet Educ 2024;36(1):26–35.
  46. Viner B. Clinical audit in veterinary practice—the story so far. Practice 2005;27(4):215–218.
    doi: 10.1136/inpract.27.4.215google scholar: lookup
  47. Burgess R, Moorhead J. New principles of best practice in clinical audit. 2nd ed. Oxford: Radcliffe Publishing; 2011. p. 1–57.
    doi: 10.1201/9781003155393google scholar: lookup
  48. European Medicines Agency (EMA), Committee for Medicinal Products for Veterinary Use (CVMP), Committee for Medicinal Products for Human Use (CHMP). Categorisation of antibiotics in the European Union. Amsterdam: EMA; 2019.
  49. World Health Organization (WHO). Critically important antimicrobials for human medicine, 6th rev. Geneva: WHO; 2019.
  50. Theelen MJP, Wilson WD, Byrne BA, Edman JM, Kass PH, Magdesian KG. Initial antimicrobial treatment of foals with sepsis: do our choices make a difference?. Vet J 2019;243:74–76.
    doi: 10.1016/j.tvjl.2018.11.012google scholar: lookup
  51. BEVA. Protect me toolkit. Cambridge: BEVA (British Equine Veterinary Association); 2020.
  52. Hardefeldt LY, Bailey KE, Slater J. Overview of the use of antimicrobial drugs for the treatment of bacterial infections in horses. Equine Vet Educ 2021;33(11):602–611.
    doi: 10.1111/eve.13371google scholar: lookup
  53. Floyd EF, Easton‐Jones EA, Theelen MJP. Systemic antimicrobial therapy in foals. Equine Vet Educ 2022;34(1):49–56.
    doi: 10.1111/eve.13467google scholar: lookup
  54. Ares‐Mazàs E, Lorenzo MJ, Casal JA, Fernàndez Da Ponte B, Castro JA, Freire F. Effect of a commercial disinfectant (“Virkon”) on mouse experimental infection by Cryptosporidium parvum. J Hosp Infect 1997;36:141–145.
    doi: 10.1016/s0195-6701(97)90120-1google scholar: lookup
  55. Weir SC, Pokorny NJ, Carreno RA, Trevors JT, Lee H. Efficacy of common laboratory disinfectants on the infectivity of Cryptosporidium parvum oocysts in cell culture. Appl Environ Microbiol 2002;68:2576–2579.
    doi: 10.1128/aem.68.5.2576-2579.2002google scholar: lookup
  56. Dunowska M, Patterson G. Recent progress in controlling Salmonella in veterinary hospitals. Proc Annu Conv Am Assoc Equine Pract 2004;50:350–353.
  57. Dunowska M, Morley PS, Hyatt DR. The effect of Virkon S fogging on survival of Salmonella enterica and Staphylococcus aureus on surfaces in a veterinary teaching hospital. Vet Microbiol 2005;105(3–4):281–289.
    doi: 10.1016/j.vetmic.2004.11.011google scholar: lookup
  58. Dallap Schaer BL, Aceto H, Rankin SC. Outbreak of salmonellosis caused by Salmonella enterica serovar Newport MDR‐AmpC in a large animal veterinary teaching hospital. J Vet Intern Med 2010;24(5):1138–1146.
    doi: 10.1111/j.1939-1676.2010.0546.xgoogle scholar: lookup
  59. Brewer BD, Koterba AM, Carter RL, Rowe ED. Comparison of empirically developed sepsis score with a computer generated and weighted scoring system for the identification of sepsis in the equine neonate. Equine Vet J 1988;20:23–24.
  60. Roy MF, Kwong GPS, Lambert J, Massie S, Lockhart S. Prognostic value and development of a scoring system in horses with systemic inflammatory response syndrome. Equine Vet J 2017;49(1):45–52.
    doi: 10.1111/jvim.14670google scholar: lookup
  61. Wong DM, Ruby RE, Dembek KA, Barr BS, Reuss SM, Magdesian KG. Evaluation of updated sepsis scoring systems and systemic inflammatory response syndrome criteria and their association with sepsis in equine neonates. J Vet Intern Med 2018;32:1185–1193.
    doi: 10.1111/jvim.15087google scholar: lookup
  62. Palmer JE. Neonatal drug dosages. 6th ed. San Antonio, TX: IVECCS; 2000.
  63. Maddox TW, Scantlebury CE, Clegg PD, Dawson S, Pinchbeck GL, Williams NJ. Review of the characteristics and treatment of methicillin‐resistant Staphylococcus aureus (MRSA) in the horse and a case series of MRSA infection in four horses. Equine Vet Educ 2010;22(2):91–102.
    doi: 10.1111/j.2042-3292.2009.00026.xgoogle scholar: lookup
  64. Roudaud M, Allano M, Fairbrother JH, Sauvé F. A retrospective study on methicillin‐resistant staphylococcus spp. isolated from horses admitted to a Canadian veterinary teaching hospital between 2008 and 2018. Can Vet J 2020;61(11):1197–1202.
  65. Olivo G, Zakia LS, Ribeiro MG, Ribeiro de Souza da Cunha ML, Riboli DFM, Mello PL. Methicillin‐resistant Staphylococcus spp. investigation in hospitalized horses and contacting personnel in a teaching veterinary hospital. J Equine Vet Sci 2024;134:105031.
  66. Maddox TW, Clegg PD, Williams NJ, Pinchbeck GL. Antimicrobial resistance in bacteria from horses: epidemiology of antimicrobial resistance. Equine Vet J 2015;47(6):756–765.
    doi: 10.1111/evj.12471google scholar: lookup
  67. Becker K, Heilmann C, Peters G. Coagulase‐negative staphylococci. Clin Microbiol Rev 2014;27(4):870–926.
    doi: 10.1128/cmr.00109-13google scholar: lookup
  68. Corrente M, D'Abramo M, Latronico F, Greco MF, Bellacicco AL, Greco G. Methicillin‐resistant coagulase‐negative staphylococci isolated from horses. New Microbiol 2009;32(3):311.
  69. Kern A, Perreten V. Clinical and molecular features of methicillin‐resistant, coagulase‐negative staphylococci of pets and horses. J Antimicrob Chemother 2013;68(6):1256–1266.
    doi: 10.1093/jac/dkt020google scholar: lookup
  70. Adams RJ, Mollenkopf DF, Mathys DA, Whittle A, Ballash GA, Mudge M. Prevalence of extended‐spectrum cephalosporin‐, carbapenem‐, and fluoroquinolone‐resistant members of the family Enterobacteriaceae isolated from the feces of horses and hospital surfaces at two equine specialty hospitals. J Am Vet Med Assoc 2021;258(7):758–767.
    doi: 10.2460/javma.258.7.758google scholar: lookup
  71. Kock R, Daniels‐Haardt I, Becker K, Mellmann A, Friedrich AW, Mevius D. Carbapenem‐resistant Enterobacteriaceae in wildlife, food‐producing, and companion animals: a systematic review. Clin Microbiol Infect 2018;24:1241–1250.
  72. Silva JM, Menezes J, Marques C, Pomba CF. Companion animals—an overlooked and misdiagnosed reservoir of carbapenem resistance. Antibiotics 2022;11:533.
    doi: 10.3390/antibiotics11040533google scholar: lookup
  73. Mancuso G, De Gaetano S, Midiri A, Zummo S, Biondo C. The challenge of overcoming antibiotic resistance in carbapenem‐resistant gram‐negative bacteria: “attack on titan”. Microorganisms 2023;11(8):1912.
    doi: 10.3390/microorganisms11081912google scholar: lookup
  74. Rincón‐Real AA, Suárez‐Alfonso MC. Carbapenem resistance in critically important human pathogens isolated from companion animals: a systematic literature review. Osong Public Health Res Perspect 2022;13(6):407–423.
    doi: 10.24171/j.phrp.2022.0033google scholar: lookup
  75. World Health Organization. Bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: WHO; 2024.
  76. Scarpellini R, Pulido‐Vadillo M, Serna C, Gonzalez‐Zorn B, Blanco JL, Delgado‐Blas JF. High frequency of detection of NDM‐producing Enterobacterales among companion animals hospitalized in an Italian veterinary teaching hospital. Transbound Emerg Dis 2025;2025:2622185.
    doi: 10.1155/tbed/2622185google scholar: lookup
  77. Ward MP, Brady TH, Couëtil LL, Liljebjelke K, Maurer JJ, Wu CC. Investigation and control of an outbreak of salmonellosis caused by multidrug‐resistant Salmonella typhimurium in a population of hospitalized horses. Vet Microbiol 2005;107(3–4):233–240.
    doi: 10.1016/j.vetmic.2005.01.019google scholar: lookup
  78. Steneroden KK, Van Metre DC, Jackson C, Morley PS. Detection and control of a nosocomial outbreak caused by Salmonella Newport at a large animal hospital. J Vet Intern Med 2010;24(3):606–616.
    doi: 10.1111/j.1939-1676.2010.0484.xgoogle scholar: lookup
  79. Bergström K, Aspan A, Landén A, Johnston C, Grönlund‐Andersson U. The first nosocomial outbreak of methicillin‐resistant Staphylococcus aureus in horses in Sweden. Acta Vet Scand 2012;54:11.
    doi: 10.1186/1751-0147-54-11google scholar: lookup
  80. Piva S, Caffara M, Pasquali F, Castagnetti C, Iacono E, Massella E. Detection and quantification of Cryptosporidium oocysts in environmental surfaces of an equine perinatology unit. Prev Vet Med 2016;130:105–110.
    doi: 10.1016/j.prevetmed.2016.04.012google scholar: lookup
  81. Soza‐Ossandón P, Rivera D, Tardone R, Riquelme‐Neira R, García P, Hamilton‐West C. Widespread environmental presence of multidrug‐resistant Salmonella in an equine veterinary hospital that received local and international horses. Front Vet Sci 2020;7:346.
    doi: 10.3389/fvets.2020.00346google scholar: lookup
  82. Weese JS. Barrier precautions, isolation protocols, and personal hygiene in veterinary hospitals. Vet Clin North Am Equine Pract 2005;20(3):543–559.
    doi: 10.1016/j.cveq.2004.07.006google scholar: lookup
  83. . AAEP Biosecurity Guidelines. 2022.
  84. Feighery S. Ensuring clinic and personnel biosecurity in an equine hospital: developing an infection control policy. Vet Ireland J 2019;9(11):602–605.
  85. Timofte D, Jepson RE. Environmental microbiological surveillance does support infection control in veterinary hospitals. JAC Antimicrob Resist 2024;6(4):113.
    doi: 10.1093/jacamr/dlae113google scholar: lookup
  86. Zendri F, Isgren CM, Devaney J, Schmidt V, Rankin R, Timofte D. Resistome‐based surveillance identifies ESKAPE pathogens as the predominant gram‐negative organisms circulating in veterinary hospitals. Front Microbiol 2023;14:1252216.
    doi: 10.3389/fmicb.2023.1252216google scholar: lookup
  87. Sinclair C, Schofield I, Mair T. Antibiotic use in first opinion equine practice in the United Kingdom: serial point prevalence surveys in 17 practices. Equine Vet Educ 2025;37:68–75.
    doi: 10.1111/eve.13945google scholar: lookup
  88. Mair TS, Parkin TD. Audit of antimicrobial use in eleven equine practices over a five‐year period (2014–2018). Equine Vet Educ 2020;33(11):592–598.
    doi: 10.1111/eve.13438google scholar: lookup
  89. Jacobsen ABJE, Damborg P, Hopster‐Iversen C. Usage of antimicrobials in equine veterinary practice in Denmark—a case‐based survey. J Equine Vet Sci 2023;124:104267.
    doi: 10.1016/j.jevs.2023.104267google scholar: lookup
  90. Rockow M, Griffenhagen G, Landolt G, Hendrickson D, Pezzanite L. Current antimicrobial use in horses undergoing exploratory celiotomy: a survey of board‐certified equine specialists. Animals 2023;13(9):1433.
    doi: 10.3390/ani13091433google scholar: lookup
  91. Tallon RE, Whitt B, Bladon BM. Antibiotic usage in 14 equine practices over a 10‐year period (2012–2021). Equine Vet J 2023;55(5):650–658.
    doi: 10.1111/evj.13988google scholar: lookup
  92. Wilson A, Mair T, Williams N, McGowan C, Pinchbeck G. Antimicrobial prescribing and antimicrobial resistance surveillance in equine practice. Equine Vet J 2023;55(3):494–505.
    doi: 10.1111/evj.13587google scholar: lookup
  93. Memoli G, Lanci A, Bacci S, Bullone M, Badino P, Odore R. Antimicrobial prescribing practice at three equine veterinary teaching hospitals in Italy. J Vet Pharmacol Ther 2023;46(6):1200–1208.
    doi: 10.1111/jvp.13299google scholar: lookup
  94. Lawson A, Farrell S, Singleton D, Mair T, Freccero F, Malalana F. Multinational survey of equine veterinarians: awareness and use of antimicrobial stewardship guidelines. Equine Vet J 2024;56:24–25.
    doi: 10.1111/evj.14175google scholar: lookup
  95. Dunkel B, Johns IC. Antimicrobial use in critically ill horses. Vet Educ 2015;27(7):348–355.
    doi: 10.1111/vec.12275google scholar: lookup
  96. Dunkel B. Responsible antimicrobial use in critically ill adult horses. Equine Vet Educ 2021;33(12):653–658.
    doi: 10.1111/eve.13334google scholar: lookup
  97. Durie I, van Galen G. Can the use of antimicrobials in adult equine patients with acute colitis be justified in the era of antimicrobial stewardship?. Equine Vet Educ 2022;35:103–112.
    doi: 10.1111/eve.13657google scholar: lookup
  98. Isgren CM. Improving clinical outcomes via responsible antimicrobial use in horses. Equine Vet Educ 2022;34(9):482–492.
    doi: 10.1111/eve.13502google scholar: lookup
  99. Higgins C, Huber L. Rhodococcus equi: challenges to treat infections and to mitigate antimicrobial resistance. J Equine Vet Sci 2023;127:104845.
    doi: 10.1016/j.jevs.2023.104845google scholar: lookup
  100. Ryan CA, McNeal CD, Credille BC. Ceftiofur use and antimicrobial stewardship in the horse. Equine Vet J 2023;55(6):944–961.
    doi: 10.1111/evj.13930google scholar: lookup
  101. Gustaffson K, Sykes BW, Verwilghen D, Palmers K, Sullivan S, van Galen G. Trimethoprim‐sulfonamide: a valid antimicrobial treatment in foals?. JAVMA 2024;262(6):825–833.
    doi: 10.2460/javma.23.09.0536google scholar: lookup
  102. Shnaiderman‐Torban A, Navon‐Venezia S, Dor Z, Paitan Y, Arielly H, Abu Ahmad W. Extended‐spectrum beta‐lactamase‐producing Enterobacteriaceae shedding in farm horses versus hospitalized horses: prevalence and risk factors. Animals 2020;10:282.
    doi: 10.3390/ani10020282google scholar: lookup
  103. Freeman KD, Southwood LL, Lane J, Lindborg S, Aceto HW. Post‐operative infection, pyrexia and perioperative antimicrobial drug use in surgical colic patients. Equine Vet J 2012;44:476–481.
  104. Durward‐Akhurst SA, Mair TS, Boston R, Dunkel B. Comparison of two antimicrobial regimens on the prevalence of incisional infections after colic surgery. Vet Rec 2013;172:287.
  105. Donà D, Barbieri E, Daverio M, Lundin R, Giaquinto C, Zaoutis T. Implementation and impact of pediatric antimicrobial stewardship programs: a systematic scoping review. Antimicrob Resist Infect Control 2020;9:3.
    doi: 10.1186/s13756-019-0659-3google scholar: lookup
  106. Walther B, Lübke‐Becker A, Stamm I, Kuehner S, Mäder U, Schauer B. Suspected nosocomial infections with multi‐drug‐resistant E. Coli, including extended‐spectrum beta‐lactamase (ESBL)‐producing strains, in an equine clinic. Berl Munch Tierarztl Wochenschr 2014;127(11–12):421–427.
  107. Ogrinc G, Davies L, Goodman D. SQUIRE‐EDU (standards for QUality improvement reporting excellence: education): revised publication guidelines from a detailed consensus process. Acad Med 2019;94(10):1497–1503.
  108. Duncan EM, O'Cathain A, Fletcher A, Duncan E, Rousseau N, Croot L. Guidance for reporting intervention development studies in health research (GUIDED): an evidence‐based consensus study. BMJ Open 2020;10(5):e033516.
    doi: 10.1136/bmjopen-2019-033516google scholar: lookup
  109. World Health Organization. The evolving threat of antimicrobial resistance: options for action. Geneva: WHO; 2012.

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 106,356 horse owners like you who receive our email updates on horse health and nutrition.